ProPhase Labs Unveils Project ZenQ-AI
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Apr 24
Leveraging ProPhase Labs’ AI platform, massive genomics database and patented esophageal cancer insights for Antibody Drug Conjugates development
13 Mar 24
Under the partnership, Dassault Systèmes, a science-based firm with virtual twin experiences, and CDR-Life will study the stability…
13 Mar 24
GV20 Therapeutics will leverage the resources provided by NVIDIA Inception to develop new AI models for drug discovery,…
29 Feb 24
Ginkgo Bioworks has acquired synthetic biology company Patch Biosciences, pharmaceutical company Reverie Labs, and CRISPR-based diagnostic test developer…
29 Feb 24
Under the agreement, Viatris will get exclusive global development and commercialisation rights to these assets along with the…
28 Feb 24
Proceeds from the financing are expected to be used to support Denali’s ongoing research and development activities, the…
22 Feb 24
This new alliance provides early-stage biotechnology companies a unique solution to rapidly transition from pre-clinical activities to first-in-human…
22 Feb 24
ActivMab platform enables the discovery and development of high value antibodies against challenging multi-pass membrane targets
21 Feb 24
The partnership agreement provides Charles River with broad access to highly characterised stem cell lines including embryonic stem…
19 Feb 24
Everest Medicines is a biopharmaceutical company focused on developing, manufacturing and commercializing transformative pharmaceutical products and vaccines that…